Biobank: Biobank for individuals with prostate cancer - Biobank for prostate cancer controls (Sweden): Difference between revisions
No edit summary |
No edit summary |
||
| Line 8: | Line 8: | ||
'''Type of information:''' The participants had to submit a blood sample and answer questions regarding previous medication, height, weight, alcohol and smoking consumption. [https://snd.gu.se/sv/catalogue/dataset/ext0138-2 Click here to learn more]. | '''Type of information:''' The participants had to submit a blood sample and answer questions regarding previous medication, height, weight, alcohol and smoking consumption. [https://snd.gu.se/sv/catalogue/dataset/ext0138-2 Click here to learn more]. | ||
'''Source of information:''' | '''Source of information:''' Prostate cancer patients treated in an oncology clinic in southern Sweden were invited to participate in the study. | ||
'''Data level:''' [[dataLevel::patient level]]. | '''Data level:''' [[dataLevel::patient level]]. | ||
Revision as of 13:48, 22 May 2024
Go back to Sweden page
Primary purpose: Store the sample collection and data information to study risk factors for prostate cancer.
Sponsor, manager or home institution: Lund University.
Type of information: The participants had to submit a blood sample and answer questions regarding previous medication, height, weight, alcohol and smoking consumption. Click here to learn more.
Source of information: Prostate cancer patients treated in an oncology clinic in southern Sweden were invited to participate in the study.
Data level: patient level.
Number of records: 1000. Click here to learn more.
Date range: 2007 onwards.
Cancer areas of interest: C60-C63: Male genitalia cancer. Click here to learn more.
Data access: not publicly available. Dataset information and contact to request data: Click here to learn more. Instructions to request data for restricted content: click here to learn more.
Contact information: Click here to learn more.
